The relaxivity displayed by Gd 3+ chelates immobilized onto gold nanoparticles is the result of complex interplay between nanoparticle size, water exchange rate and chelate structure. In this work we study the effect of the length of -thioalkyl linkers, 
Introduction
MRI is becoming the "central imaging modality" in clinical diagnostic. 1 MRI is based on the nuclear magnetic resonance phenomenon (NMR). In MRI scans, essentially, the relaxation times (T1 and T2) of the water protons of tissues (intrinsically different) are acquired and reconstructed into tridimensional anatomical images. 2, 3 MRI is inherently non-invasive, makes use of (benign) non-ionizing radiation (static and radiofrequency magnetic fields), is depth independent and displays superb spatial resolution. Low detection sensitivity (inherent to the NMR phenomenon) is the main limitation of MRI. 4 Contrast Agents (CA) are paramagnetic species (Gd 3+ , Mn 2+ , Fe 3+ , stable organic radicals, iron oxide nanoparticles, etc.) that by promoting selective reduction of T1 or T2 of the water protons of tissues can generate dramatic contrast enhancements. 5, 6 The selective enhancement of the relaxation rates, R1,2, (R1,2 = 1/T1,2), normalized to 1 mM concentration of paramagnetic centres -relaxivity (r1,2, units mM -1 s -1 ), measures CA efficacy. 4, 7 Approved CA for clinical MRI are either Gd 3+ complexes with linear (DTPA-type) and macrocyclic (DOTA-type) poly(aminocarboxylate) ligands (T1-weighed MRI) 8 or iron oxide nanoparticles (IONPS) stabilized with dextran (T2-T2*-weighed MRI). 9 Low molecular weight Gd 3+ -based CA display relaxivities of the order of magnitude 3-5 mM -1 s -1 at magnetic fields relevant (currently) for clinical MRI . The Solomon-Bloembergen-Morgan (SBM) theory predicts that very high relaxivities, of the order of magnitude 100 mM -1 s -1 at magnetic fields relevant for clinical imaging , are attainable by Gd 3+ chelates displaying simultaneous optimization of the main parameters that govern relaxivity: rotational correlation times (R), water exchange rate constant (kex) and electron relaxation parameters (v and  2 ). 4, 7 Despite great advancements in the design and synthesis of CA during the past two decades, the ideal CA-displaying very high relaxivity and safety in vivo, targeting capability and responsiveness coupled to therapeutic properties, is still elusive. 10 The "nanotechnology revolution" is underway with a dramatic impact in many fields, particularly in medical imaging. 11 Gold nanostructures (nanoparticles, nanoclusters, nanorods, etc) are finding many applications in chemistry, medicine, biotechnology and other fields, owing to intrinsic reporting properties (localized surface plasmon resonance, fluorescence, X-Ray attenuation) 12 coupled to therapeutic properties (hyperthermia, X-ray sensitization), 13 biocompatibility and safety in vivo 14 and facile preparation with tunable size and surface properties by bottom-up methodologies. 15 The first generation of gold nanoparticles (AuNPs) CA made use of, easy to synthesize, thiol-functionalised Gd(DTPA-bis-amide) [16] [17] [18] and Gd(DO3A)-type chelates. 19 Superb relaxivities (per nanoparticle) were attained thanks to chelate clustering. 16 In vivo MRI studies established the merits of AuNPs as CA for MRI, bimodal MRI/X-ray imaging and as theragnostics (MRI/X-ray sensitization). [16] [17] [18] 20 Slow water exchange and fast local rotational motions of the immobilized chelates around linkers/spacers (chelate flexibility) result in relaxivity enhancements (per chelate) lower than those expected for Gd 3+ chelates appended to rigid nanosized objects. [16] [17] [18] 21, 22 Helm and co-workers reported very high relaxivity per chelate immobilized onto AuNPs (60 mM -1 s -1 ; 30 MHz, 25 ºC), attributed to two exchanging inner sphere water molecules in Gd(DTTA)-type chelates and complete rigidity of the chelates immobilized via a short aromatic linker. 23 The relaxivity was however, still respectively, 25 ºC) as the result of simultaneous optimization of the rotational dynamics and water exchange rate. 27 Fast local rotational motions around the cysteine linker still limit the attainable relaxivity, as demonstrated before for other macromolecular/nanosized objects such as micelles, dendrimers, polymers, etc. 26, 27, 28 In this work we address the effect of the length of the -thioalkyl linker, anchoring fast water exchanging Gd[DO3A-N-(-amido)propionate] chelates to gold nanoparticles, on the relaxivity. Biodistribution and in vivo MRI studies with the functionalized AuNPs as CA are reported also.
Synthesis and characterization
Mercaptoundecanoyl and lipoyl conjugates of the DO3A-N-(-amino)propionate chelator were synthesized to study the effect of the length of the -thioalkyl linker on the relaxivity of AuNPs functionalized with Gd 3+ chelates (Scheme1).
Scheme 1.
Synthetic pathway for -thioalkyl conjugates of the DO3A-N-(-amino)propionate chelator: a) K2CO3/MeCN; b) ethyl bromoacetate, K2CO3/MeCN; c) i. TFA/CH2Cl2, ii. DIPEA/CH2Cl2, lipoic acid, DCC/HOBt; d) i) TFA/DCM, ii. Ethyl bromoacetate, K2CO3/MeCN; e) i. NaOH aq., ii. Flash chromatography silica gel, iii. SEM (Sephadex G10); f) GdCl3.6H2O; g) i. HAuCl4, NaBH4, ii. GdCl3.6H2O, iii. SEM (Sephadex G10) followed by dialysis (cellulose tubing MWCO 10 KDa).
The lipoic acid conjugate (L1) was prepared following the synthetic methodology reported before for the cysteine conjugate of the DO3A-N-(-amino)propionate chelator (L3). 27 The synthetic pathway excludes, all along, acidic conditions likely to promote oligomerization of the chelator through the lipoic acid moiety. 29 Deprotection of the fully alkylated orthogonally protected intermediate 6 allows direct conjugation of lipoic acid to the preformed DO3A-N--(amino)propionate scaffold. 27 For preparing the 11-mercaptoundecanoyl conjugate (L2) the preformed amide was introduced into the cyclen scaffold via Michael addition of the N-Boc,N- (11- (acetylthio)undecanoyl)dehydroalanine methyl ester electrophile (3). 25, 26 Reactive block 3 was prepared over 3 steps in 48 % overall yield (Scheme 2). The thioacetyl protecting group proved easy to install and stable under mild alkaline and strong acidic conditions en route to L2. Final deprotection was performed in one step by saponification with ethanolic NaOH. Following pH adjustment to neutrality with diluted hydrochloric acid, chelators L1 and L2 were adsorbed onto silica and purified by flash chromatography followed by Size Exclusion Chromatography (SEC) on Sepahdex G10 with water elution.
Relaxometric studies of GdL1 and GdL2
The concentration dependence of the paramagnetic longitudinal water proton relaxation rate (R1p) was measured for GdL1 and GdL2 (20 MHz, 25 ºC, pH 7.1) ( Figure   1 ). The relaxation rate data for GdL1 can be well fitted to a straight line (Equation and 2). The concentration at the interception of the two lines defines the critical micelle concentration-cmc (cmc = 1.5 ± 0.3 mM). As both GdL2 and Gd[DO3A-N-(-pyrenebutanamido)propionate] chelates display fast water exchange, the lower relaxivity attained by GdL2 has to be ascribed to higher internal flexibility and/or smaller size of the GdL2 micelles ( Figure SI2 ). The pH dependence of the proton relaxation rate ( Figure SI3 ) and the transmetallation study ( Figure SI4 ) show that GdL1 
Characterization of GdL1@AuNPs and GdL2@AuNPs preparations
The Gd content of the functionalized AuNPs was estimated by bulk magnetic susceptibility measurements 36 and further confirmed by ICP-OES following sample digestion with aqua regia (HCl/HNO3; 3/1 v/v) ( Table 1) . 27, 37 The AuNPs were characterized regarding size distribution by Dynamic Light Scattering GdL1 and GdL2 bonded to one or two Au atoms (1.9 and 2.5 nm, respectively) ( Figure   SI5 , Table SI2 ). 23, 24 The absence of a well-defined plasmon absorption band in the UVVis spectra of GdL1@AuNPs and GdL2@AuNPs ( Figure SI6 and SI7), corroborates the very small size of the NPs core.
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f Revised value according to semi-empirical calculations for the length of GdL3.
As L1, L2 and L3 share the same coordination cage, the length of the linker defines the overall wedge-like geometry of the chelator. Shorter linkers originate bulkier thiol ligands. Ligand bulkiness decreases in the series L3>L1>L2 ( Figure SI5 ). Bulkier thiols are likely to terminate the growth of AuNPs earlier than less bulky ligands, resulting in AuNPs displaying smaller Au cores associated to higher surface curvature. 39 This correlation (DAu = 1.0, 0.9 and 0.7 nm, for GdL1, GdL2 and GdL3@AuNPs) is followed roughly by L2 and L3. The discrepancy observed for L1 can be due to the different sulfur binding mode.
GdL1@AuNPs and GdL2@AuNPs were found to be stable in solution for extended periods. The NPs could be freeze-dried and re-dissolved without aggregation/precipitation. This can be ascribed to the overall negative charge (-1) of the immobilized Gd 3+ complexes, resulting in NPs displaying negative zeta-potential ( Figure SI8 ).
Relaxometric characterization of GdL1@AuNPs and GdL2@AuNPs
The concentration dependence of the proton longitudinal relaxation rate (R1p) was evaluated for GdL1@AuNPs and GdL2@AuNPs (r1 = 29 and 38 mM -1 s
respectively, 20 MHz, 25 ºC, pH 7.1) ( Figure SI9 ).
For relevant clinical applications chelates immobilized onto NPs must be stable regarding demetallation and inert towards transmetallation with physiological metal ions, mainly Zn 2+ . 33 In addition to releasing toxic Gd 3+ , demetallation and transmetallation processes of immobilized chelates are likely to trigger particle aggregation and precipitation in vivo. Stability at low pH is particularly important as protonation-assisted mechanisms have been implicated in demetallation, presumably followed by transmetallation with serum ions, of macrocyclic Gd(DOTA)-type chelates. 33, 40, 41 The pH dependence of the protonic relaxation rate (R1p) was evaluated for GdL1@AuNPs and GdL2@AuNPs in the pH range 3-10 ( Figure SI10 ).
The kinetic stability of the immobilized chelates (and entire nanoparticles) was evaluated by challenging GdL1@AuNPs and GdL2@AuNPs with Zn 2+ ions in phosphate buffer ( Figure SI11 and Figure SI12 ). 33 According to the criteria set by
Muller and co-workers, the immobilized chelates (and whole NPs) can be classified as kinetically inert and thermodynamically stable. 33 The pH stability and kinetic inertness indicate that the NPs are potentially safe for in vivo applications.
Nuclear Magnetic Relaxation Dispersion Profiles
The magnetic field dependence of the proton relaxivity (r1) (Nuclear Magnetic
Relaxation Dispersion -NMRD profiles) was obtained for GdL1@AuNPs and
GdL2@AuNPs in the Larmor frequency range 0.01-400 MHz. The most important parameters that govern relaxivity are the hydration number (q), the water exchange rate constant (kex), the rotational correlation time (R) and the electron relaxation parameters (v and  2 ). 4, 7 The number of water molecules in the first coordination sphere, the water exchange rate and the rotational correlation time can be tuned by chelate design. Clear rules to tune the electron relaxation parameters are still elusive. 42 Treating chelates immobilised onto macromolecular/nanosized objects (micelles, proteins, polymers, dendrimers, nanoparticles, viral particles) as rigid entities, often fails to deliver reliable parameters from the fitting of the NMRD profiles to the SBM theory. In fact, it is necessary to assume in the fittings that the interactions that generate the relaxation are In this work, it was assumed in the fittings that the immobilised GdL1 and GdL2 complexes have one inner sphere water molecule (q = 1) like other Gd 3+ complexes of the DO3A-N-(α-amino/amido)propionate family. [24] [25] [26] The water exchange rate constant and its activation enthalpy (kex 298 , H ‡ ) were fixed to values determined for the analogous Gd[(DO3A-N-(-benzoylamido)propionate] chelate. 25 The fittings (continuous lines in Figure 4 ) are restricted to frequencies above 6
MHz as the SBM theory is not suitable for describing the rotational dynamics of slowrotating objects at low magnetic fields. The best fit parameters for GdL1@AuNPs and GdL2@AuNPs, obtained from the analysis of 1 H NMRD data, are represented in Figure   4 and summarized in Table 2 . Table 2 , but assuming total rigidity (S 2 = 1) of the immobilized chelates. 
Biodistribution studies
The biodistribution of [ The activity in the blood was measured after 30 minutes, 60 minutes, 2 and 24 hours (inset in Figure 6 ) revealing fast clearance of activity from the blood with a reduction of approximately 50% between 30 minutes and two hours. After 2 hours postinjection, the NPs are mainly found in the organs of the reticulo-endothelial system (RES), liver and spleen, and to a lesser extent in the blood and lungs. These results suggest that the nanoparticles are cleared mainly by phagocytosis by the macrophage rich organs, liver and spleen, with a less important contribution from renal elimination. 20, 26, 45 This is in accordance with what was found by MRI for 
Preparation of Lipoic acid conjugate DO3A-N-(α-lipoamido)propionate -L1

Synthesis of ((5-(1,2-dithiolan-3-yl)-2-pentanamido)methoxycarbonylethyl)-4,7,10-tris-(ethoxycarbonylmethyl) -1,4,7,10-tetraazacyclododecane -fully protected conjugate 7.
Orthogonally protected compound 6 was synthesized as described before by us. 27 A solution of compound 6 (85 mg; 1.12 mmol) in a mixture DCM/TFA (24 ml, 3:1, v/v) was stirred at room overnight. The solvent was removed under reduced pressure, the residue was re-dissolved in DCM and the solvent was evaporated. This procedure was repeated several times.
The resulting oil was dried under vacuum to afford a white foam. 1 
H NMR (CDCl3)
revealed the disappearance of the signals assigned to the Boc groups on compound 6.
Quantitative deprotection was assumed. The residue (1.12 mmol, assuming quantitative deprotection) was dissolved in DCM (20 ml) and the solution was adjusted to pH 9-10 
Preparation of 11-mercaptoundecanoic acid conjugate DO3A-N-(-mercaptoundecanamido)propionate -L2
Synthesis of 11-(acetylthio)undecanoic acid (10)
To an ice-cooled solution of 11-mercaptoundecanoic acid (9) (2.00 g, 9.17 mmol) in pyridine (2.6 ml) was added acetic anhydride (2.6 ml, 2.81 g, 27.5 mmol). The solution was left stirring at room temperature overnight. Ice was directly added to the reaction mixture, followed by magnetic stirring until complete melting of the ice. The mixture was extracted with ethyl acetate (3×150 ml). The organic phase was washed with brine (3x30 ml), dried (MgSO4) and the solvent was removed under reduced pressure. The residue was further dried under vacuum to afford the final compound as an off-white solid (2.12 g, 89% 
Synthesis of (11-(acetylthio)undecanoyl)serine methyl ester (11)
To an ice-cooled solution of compound 10 (2.12 g, 8.14 mmol) in acetonitrile 
Synthesis of N-(tert-butoxycarbonyl),N-(11-(acetylthio)undecanoyl) dehydroalanine methyl ester (3)
To a solution of compound (11) 
Preparation of GdL1 and GdL2 complexes for relaxometric measurements
A solution of GdCl3.6H2O was added drop-wise, under magnetic stirring, to an equimolar solution of L1 or L2 (5% excess), while keeping the solution pH around 5.8 
NMRD measurements
The NMD measurements were performed using a Stelar Spinmaster FFC NMR 
MRI studies
Preparation of the GdL1@AuNPs and GdL2@AuNPs CA solutions for MRI studies.
The GdL1@AuNPs and GdL2@AuNPs CA for the MRI studies were prepared following the procedure described above. The final nanoparticles solutions were freezedried and their Gd and Au content (per mg of solid material) were determined by ICP-OES following digestion with aqua regia.
In vivo MRI studies.
The experimental protocols were approved by the appropriate institutional review committees and meet the guidelines of their responsible governmental agency. All MRI examinations were carried out on mice (n = 4, ~ 20 g body weight)
anaesthetized initially by inhalation in an induction box with O2 (1 L/min) containing 3 % isoflurane, and maintained during the experiment using a face mask allowing free breathing and 1-2 % isoflurane on O2. Animals were taped down into a holder, to minimize breathing -related motion, and were then placed in a heated probe, which maintained the core body temperature at 37 ± 0.5 °C, monitored by a rectal probe. The physiological state of the animal was monitored throughout the entire experiment by a Biotrig physiological monitor (Bruker Medical GmbH, Ettlingen, Germany), using the respiratory rate and body temperature. National regulations for the care and use of laboratory animals were strictly followed in this study.
Semiempirical calculations, molecular modelling and NPs size estimates
All calculations were performed with Mopac code 50 using the semiempirical model Hamiltonian PM6 51 and COSMO 52 implicit water solvent model (ε= 74.8 with
Gd and Au tesserae radius taken as 0.2 nm). The length of the chelates was estimated from various chelate conformers averaged over several S…O and S…H top bottom distances within conformers ( Figure SI5) ; ascribing an error of 0.1 nm to the estimates seems reasonable for this methodology. The average AuNPs diameter is estimated from the diameter exclusion of the left and right chelates (Table SI2 ). a The synthesis and characterization of L1, L2, GdL1, GdL2 and GdL1@AuNPs and GdL2@AuNPs is described in this work.
